HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Huaier granules combined with conventional therapy may improve survival in hepatocellular carcinoma
Does adding Huaier granules help liver cancer patients live longer when combined with standard treatment?
This systematic review of 4,832 patients found that Huaier granules combined with conventional cancer therapy was associated with improved o…
Adding Huaier granules to standard liver cancer treatment helped patients live longer and slowed disease growth compared to therapy alone.
Frontiers
Apr 19, 2026
Oncology
Cohort
Plasma metabolomics panels show high discriminating power for lung, colorectal, and ovarian cancers
Blood Test Finds Unique Chemical Fingerprints for Three Major Cancers
This metabolomics biomarker discovery study analyzed plasma from 615 patients with lung, colorectal, or ovarian cancer and 95 non-cancerous …
A new blood test finds unique chemical fingerprints for lung, ovarian, and colorectal cancers with high accuracy before tumors are visible.
medRxiv
Apr 16, 2026
Oncology
Phase I
HS-20093 shows response in lung cancers in Phase 1a/b trial
New Drug Targets Deadly Lung Cancer Cells
A Phase 1a/b trial in 306 patients with previously treated advanced solid tumors found HS-20093, a B7-H3-targeted antibody-drug conjugate, h…
A new drug attacks a specific protein on lung cancer cells, helping more than half of patients with an aggressive type while remaining safe …
Apr 16, 2026
Oncology
Review finds fine-tuned AI model matches larger model in simulated lung cancer screening conversations
Small AI Model Beats Big Tech in Lung Cancer Chat
This evaluation review assesses a fine-tuned open-source AI model for lung cancer screening conversations, comparing it to a larger propriet…
A specialized, smaller AI model understands patient worries better than a huge, expensive system while keeping patients safe.
medRxiv
Apr 16, 2026
Oncology
Sys. Review
Systematic review of radionuclide theranostics in lung cancer patients
Smart Cancer Tracker Finds Lung Tumors and Fights Back
This systematic review evaluated radionuclide theranostics for patients with lung cancer. Specific study details, sample sizes, and primary …
Tiny radioactive 'smart bombs' can spot lung cancer cells on scans and then destroy them from the inside when other treatments fail.
Frontiers
Apr 15, 2026
Allergy & Immunology
Sys. Review
Systematic review examines miRNA-mediated neutrophil regulation for acute lung injury, asthma, fibrosis, and lung cancer.
Tiny Molecules in Your Blood May Control Lung Inflammation
This systematic review evaluated miRNA-mediated regulation of neutrophil dynamics as a potential therapeutic strategy for acute lung injury,…
Tiny molecules in your blood act as a switch that controls the immune cells causing lung damage in asthma, fibrosis, and cancer.
Frontiers
Apr 14, 2026
Allergy & Immunology
Cohort
In lung cancer patients, immune-checkpoint inhibitors were associated with a 16.4% incidence of thyroid irAEs.
Thyroid Trouble Might Mean Better Lung Cancer Response
This retrospective analysis of 420 lung cancer patients treated with immune-checkpoint inhibitors at a single Italian center found that 16.4…
Having a mild thyroid reaction while on cancer drugs could actually mean the medicine is working well inside your body.
Frontiers
Apr 14, 2026
Pulmonology & Critical Care
Meta-analysis
Mindfulness interventions show mixed effects on breathlessness and pulmonary function in lung cancer patients
Mindfulness helps lung function and mood in lung cancer patients, but not breathlessness
A meta-analysis of 14 RCTs involving 1,190 lung cancer patients found mindfulness-based interventions did not significantly improve breathle…
Mindfulness improved lung function and mood for cancer patients, but it did not reduce the feeling of breathlessness.
Apr 13, 2026
Oncology
Cohort
In Appalachian lung cancer patients, definitive chemoradiotherapy was associated with a 59% incidence of cardiovascular adverse events.
A Simple Heart Scan Could Predict Your Biggest Risk During Lung Cancer Treatment
This retrospective cohort study evaluated 86 Appalachian patients with lung cancer treated with definitive chemoradiotherapy at a single ins…
For many battling lung cancer, the treatment meant to save them can quietly damage their heart, and a new analysis shows who is most in dang…
medRxiv
Apr 12, 2026
Allergy & Immunology
Cohort
Proton radiotherapy linked to lower severe lymphopenia incidence than photon therapy in lung cancer
Proton Therapy May Slash a Dangerous Side Effect in Half for Lung Cancer
A retrospective cohort study of 131 lung cancer patients receiving curative-intent radiotherapy found severe radiation-induced lymphopenia (…
For lung cancer patients, the type of radiation you get—protons versus standard photons—could dramatically change your risk of a serious tre…
Frontiers
Apr 11, 2026
Infectious Disease
Sys. Review
Oncolytic viruses show promise for improving lung cancer survival outcomes via multifaceted anti-cancer mechanisms.
A new approach uses engineered viruses to target and destroy tumors.
This systematic review evaluated oncolytic viruses (OVs) compared to current primary therapeutic modalities for lung cancer. The analysis su…
Engineered viruses hunt down and destroy lung cancer cells while sparing healthy tissue, offering new hope for patients who have run out of …
Frontiers
Apr 10, 2026
Oncology
RCT
Home platform-guided nursing improves functional and psychological outcomes after lung cancer surgery in small trial
Can a smart home platform help lung cancer patients recover better after surgery?
A 50-patient randomized trial at a single Chinese hospital found that Internet + nursing services via a home intelligent management platform…
A smart home platform helped lung cancer surgery patients walk farther, feel less pain, and recover faster with less anxiety and depression.
Apr 9, 2026